|
1
|
Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS,
Myoung J, Kim BT and Kim SJ: Current status of epidemiology,
diagnosis, therapeutics, and vaccines for novel coronavirus disease
2019 (COVID-19). J Microbiol Biotechnol. 30:313–324.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Goldberg EE, Lin Q, Romero-Severson EO and
Ke R: Swift and extensive Omicron outbreak in China after sudden
exit from ‘zero-COVID’ policy. Nat Commun. 14(3888)2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Liao R, Zhou X, Ma D, Wang S, Fu P and
Zhong H: COVID-19 and outcomes in Chinese peritoneal dialysis
patients. Perit Dial Int. 44:117–124. 2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Knapp S: Diabetes and infection: Is there
a link?-A mini-review. Gerontology. 59:99–104. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ong KL, Stafford LK, Mclaughlin SA, Boyko
EJ, Vollset SE, Smith AE, Dalton BE, Duprey J, Cruz JA, Hagins H,
et al: Global, regional, and national burden of diabetes from 1990
to. 2021, with projections of prevalence to 2050: A systematic
analysis for the global burden of disease study 2021. Lancet.
402:203–234. 2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Joshi N, Caputo GM, Weitekamp MR and
Karchmer AW: Infections in patients with diabetes mellitus. N Engl
J Med. 341:1906–1912. 1999.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Muller LMAJ, Gorter KJ, Hak E, Goudzwaard
WL, Schellevis FG, Hoepelman AIM and Rutten GEHM: Increased risk of
common infections in patients with type 1 and type 2 diabetes
mellitus. Clin Infect Dis. 41:281–288. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Williams R, Karuranga S, Malanda B, Saeedi
P, Basit A, Besançon S, Bommer C, Esteghamati A, Ogurtsova K, Zhang
P and Colagiuri S: Global and regional estimates and projections of
diabetes-related health expenditure: Results from the international
diabetes federation diabetes atlas. Diabetes Res Clin Pract.
162(108072)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Vas P, Hopkins D, Feher M, Rubino F and B
Whyte M: Diabetes, obesity and COVID-19: A complex interplay.
Diabetes Obes Metab. 22:1892–1896. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Drucker DJ: Diabetes, obesity, metabolism,
and SARS-CoV-2 infection: The end of the beginning. Cell Metab.
33:479–498. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fang X, Li S, Yu H, Wang P, Zhang Y, Chen
Z, Li Y, Cheng L, Li W, Jia H and Ma X: Epidemiological,
comorbidity factors with severity and prognosis of COVID-19: A
systematic review and meta-analysis. Aging (Albany NY).
12:12493–12503. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhou Y, Chi J, Lv W and Wang Y: Obesity
and diabetes as high-risk factors for severe coronavirus disease
2019 (Covid-19). Diabetes Metab Res Rev. 37(e3377)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Longmore DK, Miller JE, Bekkering S, Saner
C, Mifsud E, Zhu Y, Saffery R, Nichol A, Colditz G, Short KR and
Burgner DP: International BMI-COVID consortium. Diabetes and
overweight/obesity are independent, nonadditive risk factors for
in-hospital severity of COVID-19: An international, multicenter
retrospective meta-analysis. Diabetes Care. 44:1281–1290.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Qu HQ, Qu J, Glessner J and Hakonarson H:
Mendelian randomization study of obesity and type 2 diabetes in
hospitalized COVID-19 patients. Metabolism. 129:155–156.
2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Fox T, Ruddiman K, Lo KB, Peterson E,
DeJoy R III, Salacup G, Pelayo J, Bhargav R, Gul F, Albano J, et
al: The relationship between diabetes and clinical outcomes in
COVID-19: A single-center retrospective analysis. Acta Diabetol.
58:33–38. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
China NHC. New coronavirus pneumonia
prevention and control protocol. 10th edition. National Health
Commission of the People's Republic of China, 2022.
|
|
17
|
Chan JWM, Ng CK, Chan YH, Mok TYW, Lee S,
Chu SYY, Law WL, Lee MP and Li PC: Short term outcome and risk
factors for adverse clinical outcomes in adults with severe acute
respiratory syndrome (SARS). Thorax. 58:686–689. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Schoen K, Horvat N, Guerreiro NFC, de
Castro I and de Giassi KS: Spectrum of clinical and radiographic
findings in patients with diagnosis of H1N1 and correlation with
clinical severity. BMC Infect Dis. 19(964)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yang JK, Feng Y, Yuan MY, Yuan SY, Fu HJ,
Wu BY, Sun GZ, Yang GR, Zhang XL, Wang L, et al: Plasma glucose
levels and diabetes are independent predictors for mortality and
morbidity in patients with SARS. Diabet Med. 23:623–628.
2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Banik GR, Alqahtani AS, Booy R and Rashid
H: Risk factors for severity and mortality in patients with
MERS-CoV: Analysis of publicly available data from Saudi Arabia.
Virol Sin. 31:81–84. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,
Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk
factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: A retrospective cohort study. Lancet. 395:1054–1062.
2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ismail L, Materwala H and Al Kaabi J:
Association of risk factors with type 2 diabetes: A systematic
review. Comput Struct Biotechnol J. 19:1759–1785. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zheng F, Tang W, Li H, Huang YX, Xie YL
and Zhou ZG: Clinical characteristics of 161 cases of corona virus
disease 2019 (COVID-19) in Changsha. Eur Rev Med Pharmacol Sci.
24:3404–3410. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He
JX, Liu L, Shan H, Lei CL, Hui DSC, et al: Clinical characteristics
of coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Le Gal G, Righini M and Wells PS: D-dimer
for pulmonary embolism. JAMA. 313:1668–1669. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Frost SD, Brotman DJ and Michota FA:
Rational use of D-dimer measurement to exclude acute venous
thromboembolic disease. Mayo Clin Proc. 78:1385–1391.
2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tregoning JS, Flight KE, Higham SL, Wang Z
and Pierce BF: Progress of the COVID-19 vaccine effort: Viruses,
vaccines and variants versus efficacy, effectiveness and escape.
Nat Rev Immunol. 21:626–636. 2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ledford H: COVID antiviral pills: What
scientists still want to know. Nature. 599:358–359. 2021.PubMed/NCBI View Article : Google Scholar
|
